Improving breath control for breast cancer radiotherapy
The Impact of Patients' Daily Independent Breathing Training on the Accuracy and Side Effects of Deep Inspiratory Breath-Hold Radiotherapy for Breast Cancer
This study tests whether using portable breathing devices to help breast cancer patients practice breath control can improve their radiotherapy treatment and protect healthy organs.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 80 (estimated) |
| Sex | Female |
| Sponsor | Zhejiang Hospital Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Hangzhou, Zhejiang) |
| Trial ID | NCT06488391 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of respiratory training on patients undergoing Deep Inspiration Breath Hold (DIBH) radiotherapy for breast cancer. It utilizes portable devices that allow patients to perform daily breathing exercises independently, aiming to enhance their breath-holding capabilities. The control group receives only verbal instructions without the use of these devices. The study evaluates the effectiveness of this intervention in improving treatment precision and minimizing radiation exposure to vital organs.
Who should consider this trial
Good fit: Ideal candidates are breast cancer patients who are undergoing radiotherapy and can hold their breath for more than 10 seconds.
Not a fit: Patients who cannot hold their breath for more than 10 seconds will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to more effective and safer radiotherapy for breast cancer patients by reducing radiation exposure to healthy tissues.
How similar studies have performed: While the specific approach of using portable devices for respiratory training may be novel, similar studies have shown that improved breath control can enhance the effectiveness of radiotherapy.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Breast Cancer Radiotherapy Patients * A single breath-hold can last for more than 10 seconds Exclusion Criteria: * A single breath-hold can last for more than 10 seconds
Where this trial is running
Hangzhou, Zhejiang
- Zhejiang Hospital — Hangzhou, Zhejiang, China (Recruiting)
Study contacts
- Study coordinator: Jianjun Lai
- Email: 385806945@qq.com
- Phone: +8615924193343
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.